NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Tuesday, October 30th. Stockholders of record on Friday, December 14th will be given a dividend of $0.335 per share on Wednesday, January 2nd. This represents a $1.34 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend is Thursday, December 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Wednesday, November, 7th. The specialty chemicals company reported $1.31 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.25 by $0.06. The specialty chemicals company had revenue of $778 million for the quarter, compared to analyst estimates of $796.79 million. Albemarle had a net margin of 10.44% and a return on equity of 15.39%. The business's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.08 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for Albemarle.

Albemarle will be holding an earnings conference call on Thursday, February 21st at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8443471034.

Albemarle updated its FY18 earnings guidance on Wednesday, November, 7th. The company provided earnings per share guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.39. The company issued revenue guidance of $3.3-3.5 billion, compared to the consensus revenue estimate of $3.37 billion.Albemarle also updated its FY 2018 guidance to $5.30-5.50 EPS.

18 brokerages have issued 1-year target prices for Albemarle's shares. Their forecasts range from $59.00 to $150.00. On average, they anticipate Albemarle's share price to reach $112.0339 in the next twelve months. This suggests a possible upside of 51.6% from the stock's current price. View Analyst Price Targets for Albemarle.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

News headlines about ALB stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Albemarle earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned news headlines about the specialty chemicals company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the stock's share price in the next few days.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), PolyOne (POL), Trinseo (TSE), Rogers (ROG), AdvanSix (ASIX), Kraton (KRA), Cereplast (CERPQ), A Schulman (SHLM) and ForceField Energy (FNRG).

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include KAMES CAPITAL plc (0.50%), Scout Investments Inc. (0.22%), Personal Capital Advisors Corp (0.16%), Professional Advisory Services Inc. (0.09%), Centre Asset Management LLC (0.06%) and Bank of Montreal Can (0.06%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY, Personal Capital Advisors Corp, Bank of Montreal Can, Beech Hill Advisors Inc., Regent Investment Management LLC, Centre Asset Management LLC, Appleton Partners Inc. MA and Bangor Savings Bank. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, DNB Asset Management AS, New England Research & Management Inc., Strs Ohio, Landsberg Bennett & Dubbaneh LLC, Virtu Financial LLC, Scout Investments Inc. and Hudson Valley Investment Advisors Inc. ADV. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $73.92.

Albemarle has a market capitalization of $7.85 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]